NCIA Committee Insights: How to Increase Product Safety When We Don’t Know What “Safe” Is
NCIA’s #IndustryEssentials webinar series is our premier digital educational series featuring a variety of interactive programs allowing us to provide you timely, engaging and essential education when you need it most.
The NCIA Committee Insights series showcases content produced in partnership with one of our 15 member-led committees.
With years of research and study ahead of us, it wouldn’t be appropriate to call many manufactured cannabis products “safe.” But that doesn’t mean we need to stop selling products until all the data is in. We know enough now to make manufactured products safer than the alternatives, in other words, provide a harm reduction benefit. Join us to learn specifically about how terpene limits, both in edibles and inhalables, as well as vapor products can be manufactured so as to place them as low as reasonably possible on the risk continuum.
• Principles of harm reduction and risk continuum
• Latest thinking in terpene limits (edibles and inhalables)
• Latest thinking in vapor hardware configuration and testing
Lior Chatow, Research And Development Manager, Eybna
Ramon Alarcon, Founder + CEO, Wellness Insight Technologies, Inc.
Arnaud Dumas de Rauly, Co-Founder & CEO, Blinc Group
NCIA is leading the cannabis industry's unified and coordinated campaign to ensure our business sector is treated fairly and has the opportunity to reach its full potential. Now - more than ever - is the time to invest in your business and the future of the industry by becoming a member.